tranexamic acid has been researched along with Colorectal Cancer in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaffer, AA | 2 |
| Karanicolas, PJ | 2 |
| Davis, LE | 1 |
| Behman, R | 1 |
| Hanna, SS | 1 |
| Law, CH | 1 |
| Coburn, NG | 1 |
| Roke, R | 1 |
| Lemke, M | 1 |
| Beyfuss, KA | 1 |
| Hallet, J | 2 |
| Yuan, C | 1 |
| Jia, HD | 1 |
| Tong, XM | 1 |
| Liu, JW | 1 |
| Fuentes García, D | 1 |
| Ramírez Muñoz, G | 1 |
4 other studies available for tranexamic acid and Colorectal Cancer
| Article | Year |
|---|---|
The impact of tranexamic acid on administration of red blood cell transfusions for resection of colorectal liver metastases.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Colorectal Neoplasms; Erythrocyte Transfusion; Hepate | 2021 |
Effect of administration of tranexamic acid on reduced risk of red blood cell transfusion after resection for colorectal liver metastases.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Colorectal Neoplasms; Erythrocyte Transfusion; Humans | 2021 |
Effect of administration of tranexamic acid on reduced risk of red blood cell transfusion after resection for colorectal liver metastases - Reply.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Colorectal Neoplasms; Erythrocyte Transfusion; Humans | 2021 |
[Type A hemophilia in a man undergoing liver resection for metastasis: implications for anesthetic management].
Topics: Adenocarcinoma; Aged; Anesthesia, General; Blood Loss, Surgical; Colorectal Neoplasms; Deamino Argin | 2009 |